| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/13/1993 | WO1993008825A1 Pdgf gel formulation |
| 05/13/1993 | WO1993008824A1 Synthetic lung surfactant having antioxidant properties |
| 05/13/1993 | WO1993008823A1 Guanidinyl and related cell adhesion modulation compounds |
| 05/13/1993 | WO1993008822A1 Treatment of protozoal infection with bacitracin |
| 05/13/1993 | WO1993008821A1 Side effect inhibitor for cancer therapy |
| 05/13/1993 | WO1993008820A1 Treatment of neurological conditions by an interleukin-1 inhibiting compound |
| 05/13/1993 | WO1993008819A1 Treatment of neurological conditions by an interleukin-1 inhibiting compound |
| 05/13/1993 | WO1993008818A1 Compositions and methods for preventing adhesion formation |
| 05/13/1993 | WO1993008817A1 Cd8 binding domain peptides |
| 05/13/1993 | WO1993008816A1 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof |
| 05/13/1993 | WO1993008815A1 Pharmaceutical dipeptide compositions and methods of use thereof |
| 05/13/1993 | WO1993008812A1 Reconstituted platelet membrane vesicles |
| 05/13/1993 | WO1993008807A1 Phospholipid antimicrobial compositions |
| 05/13/1993 | WO1993008701A1 C-myc dna binding partners, motifs, screening assays, and uses thereof |
| 05/13/1993 | WO1993005807A3 Erythropoietin potentiating agents and methods for their use |
| 05/13/1993 | WO1993005751A3 Osteogenic proteins in the treatment of bone deseases |
| 05/13/1993 | DE4136513A1 Neues thrombininhibitorisches protein aus raubwanzen Consuming bugs novel thrombin protein from |
| 05/13/1993 | CA2124858A1 Suppressor and progenitor cells |
| 05/13/1993 | CA2122991A1 Transfection of vertebrate cells by homologous recombination |
| 05/13/1993 | CA2122617A1 Myogenic vector systems |
| 05/13/1993 | CA2122491A1 Tgf-.beta. type receptor cdnas and uses therefor |
| 05/13/1993 | CA2122480A1 Reconstituted platelet membrane vesicles |
| 05/13/1993 | CA2122359A1 Antigen associated with type i diabetes mellitus |
| 05/13/1993 | CA2122266A1 Cd8 binding domain peptides |
| 05/13/1993 | CA2122147A1 Phosphonepeptides with collagenase inhibiting activity |
| 05/13/1993 | CA2122024A1 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof |
| 05/13/1993 | CA2121352A1 Novel thrombin-inhibitory protein from assassin bugs |
| 05/13/1993 | CA2121246A1 Novel thrombin-inhibitory protein from ticks |
| 05/13/1993 | CA2120944A1 Stabilization of human interferon |
| 05/13/1993 | CA2116653A1 Peptides inhibiting il-1 beta release |
| 05/13/1993 | CA2099246A1 Trapped cells and use thereof as a drug |
| 05/13/1993 | CA2082748A1 Antithrombotic agents |
| 05/12/1993 | EP0541507A2 Thrombin and method for its production |
| 05/12/1993 | EP0541335A1 Recombinant DNA sequences and plasmids for cellular immunity vaccines from bacterial toxinantigen conjugates |
| 05/12/1993 | EP0541214A2 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity |
| 05/12/1993 | EP0541058A1 Expression of a mature proteinase 2a, its partial purification and preparation of inhibitory active substrates |
| 05/12/1993 | EP0540969A2 Derivatives of structurally modified VIP and pharmaceutical compositions containing them |
| 05/12/1993 | EP0540859A1 Anthracycline prodrugs |
| 05/12/1993 | EP0540747A1 Medicine for intraocular operation |
| 05/12/1993 | EP0540675A1 Inhibition of mac-1 receptor binding to fibrinogen using d 30? homologs |
| 05/12/1993 | EP0540663A1 Interleukin 8 inhibition of cytokine-induced histamine release from bosophils or mast cells |
| 05/12/1993 | EP0540645A1 Methods of use of bovine respiratory syncytial virus recombinant dna, proteins vaccines, antibodies, and transformed cells |
| 05/12/1993 | EP0540631A1 Trans-mucosal drug preparations and trans-mucosal administration |
| 05/12/1993 | EP0540626A1 Process for synthesizing peptides |
| 05/12/1993 | EP0540612A1 Heterobifunctional reagents and conjugates with oxaalkylene units for amphiphilic bridge structures |
| 05/12/1993 | EP0540599A1 Adoptive immunotherapy with interleukin-7 |
| 05/12/1993 | EP0540586A1 Binding domains |
| 05/12/1993 | EP0540575A1 Human meg-csf protein and methods |
| 05/12/1993 | EP0538268A4 Targeted protection from cytotoxins |
| 05/12/1993 | EP0525054A4 Modified heparin binding growth factors |
| 05/12/1993 | EP0160670B1 Monoclonal antibodies against endotoxin of gram-negative bacteria |
| 05/12/1993 | CN1071930A Inhibitors of hiv protease useful for treatment of aids |
| 05/12/1993 | CN1071845A Injectable extended release formulations and methods |
| 05/12/1993 | CN1071832A Pressurised aerosol compositions |
| 05/12/1993 | CN1020616C Process for preparing de-(acetylglucosaminyl)-di (dehydro)-deoxyteicoplanin derivatives |
| 05/12/1993 | CA2082450A1 Hybrid transforming growth factors |
| 05/11/1993 | US5210185 Preparing active beta subunit by homogenizing human placenta tissue, centrifuging homogenate, recovering supernatant, dialyzing to dissociate 7S NGF form, fractionating by cation exchange chromatography, purifying, polyclonal antibodies |
| 05/11/1993 | US5210183 Protein Arp, with immunoglobulin A binding activity, the corresponding vectors and hosts, reagent kit and pharmaceutical composition |
| 05/11/1993 | US5210180 Nonapeptides |
| 05/11/1993 | US5210076 Methods of treating Parkinson's disease using melanin |
| 05/11/1993 | US5210075 Interleukin 6 antagonist peptides |
| 05/11/1993 | US5210074 Method for preparing a dried composition of insulin-like growth factor i |
| 05/11/1993 | US5210073 Method for treating cancer therapy radiation damage or arteriosclerosis using human adf |
| 05/11/1993 | US5210072 Immunomodulant, suppressing IgE formation |
| 05/11/1993 | US5210028 Process for the production of unfused igf-ii protein in e. coli |
| 05/11/1993 | US5210027 DNA encoding novel antimicrobial polypeptide and methods for obtaining such polypeptide |
| 05/11/1993 | US5210026 Human mk gene and method of expression |
| 05/11/1993 | US5210017 Ligand-mediated immunofunctional hormone binding protein assay method |
| 05/11/1993 | US5209926 Aminosteroids for ophthalmic use |
| 05/11/1993 | US5209920 Arthritis, administering a stimulant for the hypothalamic-pituitary adrenal axis and measuring hormone level |
| 05/11/1993 | CA1317545C Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs |
| 05/09/1993 | WO1993009239A1 Adeno-associated virus-2 basal vectors |
| 05/09/1993 | CA2082226A1 Polypeptide, dna fragment encoding the same, drug composition containing the same and process for producing the same |
| 05/09/1993 | CA2081952A1 Recombinant dna sequences and plasmids for cellular immunity vaccines from bacterial toxin-antigen conjugates, and methods of their use |
| 05/07/1993 | CA2082217A1 Expression of mature proteinase 2a, the partial purification thereof and preparation of substrates having an inhibitory effect |
| 05/06/1993 | DE4237047A1 Drug contg. polypeptide homologous to nerve growth factor and slow virus sequence - for treating amyotrophic lateral sclerosis, spinal muscle atrophy or Parkinson's disease |
| 05/06/1993 | DE4236064A1 Selective toxic agent contg. hydrolytic enzymes - can immobilise and/or kill ecto- and endo- parasites which are pathogenic to humans and animals |
| 05/06/1993 | DE4136087A1 Neues thrombininhibitorisches protein aus zecken Tick novel thrombin protein from |
| 05/05/1993 | EP0540462A1 L-Glutamine or a peptide rich in L-glutamine for the manufacture of an oral formulation for the treatment of a fall in blood L-glutamine levels |
| 05/05/1993 | EP0540263A1 Bacterial nitroreductase for the reduction of CB 1954 and analogues thereof to a cytotoxic form |
| 05/05/1993 | EP0540128A1 Nematode vaccine |
| 05/05/1993 | EP0540063A1 Hyperimmune serum for endotoxin associated disease, detoxified endotoxin and bacterial mutant |
| 05/05/1993 | EP0539970A2 Methods for producing human lymphocytes and human monoclonal antibodies, and human monoclonal antibodies produced thereby |
| 05/05/1993 | EP0539748A1 Polypeptides capable of binding to heavy chains of IL-2 receptors |
| 05/05/1993 | EP0539573A1 Genomic modifications with homologous dna targeting |
| 05/05/1993 | EP0539522A1 Improved immunotherapeutic method of preventing or treating viral respiratory tract disease |
| 05/05/1993 | EP0539506A1 Method for treating viral infections using oxidized lipoproteins |
| 05/05/1993 | EP0539491A1 PARATHYROID HORMONE ANALOGUES MODIFIED AT POSITIONS 3, 6 or 9 |
| 05/05/1993 | EP0539457A1 Compositions based on active principles of hydrophobic medicaments solubilizable in an aqueous solvent |
| 05/05/1993 | EP0539455A1 Multivalent anti-cytokine immunoglobulins |
| 05/05/1993 | EP0539451A1 Vinylsulphonyl pristinamycin and preparation thereof. |
| 05/05/1993 | EP0539414A1 Stable and bioactive modified somatotropins |
| 05/05/1993 | EP0527806A4 Epithelins: novel cysteine - rich growth modulating proteins |
| 05/05/1993 | EP0515569A4 Calcium channel compositions and methods |
| 05/05/1993 | EP0511302A4 Cytotoxic cell-specific protease-related molecules and methods |
| 05/05/1993 | EP0486526A4 Tumour necrosis factor binding ligands |
| 05/05/1993 | EP0289584B1 Wound healing and bone regeneration |
| 05/05/1993 | EP0211077B1 Metalloproteinase inhibitor sequence recombinant vector system for using same and recombinant-dna method for the manufacture of same |
| 05/05/1993 | CN1071586A Receptor of mutation growth factor use as pharmaceutical and application for treating cancer |
| 05/05/1993 | CN1071585A Methods of treatment of motor neuron diseases using members of bdnf/nt-3/ngf family of molecule |